# Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive

> **NCT01668914** · PHASE3 · COMPLETED · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 126 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** IM-SLNB
- **RADIATION:** 99mTc-SC
- **DEVICE:** Histologic Examination
- **DEVICE:** LSG
- **DRUG:** Methylthioninium

## Key facts

- **NCT ID:** NCT01668914
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-09
- **Final completion:** 2017-12
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01668914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01668914, "Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01668914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*